These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27270099)

  • 1. Characterization of Kinetic Binding Properties of Unlabeled Ligands via a Preincubation Endpoint Binding Approach.
    Shimizu Y; Ogawa K; Nakayama M
    J Biomol Screen; 2016 Aug; 21(7):729-37. PubMed ID: 27270099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of smoothened receptor antagonists by binding kinetics against drug-resistant mutant.
    Shimizu Y; Ishii T; Ogawa K; Sasaki S; Matsui H; Nakayama M
    Eur J Pharmacol; 2015 Oct; 764():220-227. PubMed ID: 26048307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of competitive radioligand binding predicted by the law of mass action.
    Motulsky HJ; Mahan LC
    Mol Pharmacol; 1984 Jan; 25(1):1-9. PubMed ID: 6708928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α2A- and α2C-adrenoceptors.
    Uhlén S; Schiöth HB; Jahnsen JA
    Eur J Pharmacol; 2016 Oct; 788():113-121. PubMed ID: 27318322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-point competition association assay: a fast and high-throughput kinetic screening method for assessing ligand-receptor binding kinetics.
    Guo D; van Dorp EJ; Mulder-Krieger T; van Veldhoven JP; Brussee J; Ijzerman AP; Heitman LH
    J Biomol Screen; 2013 Mar; 18(3):309-20. PubMed ID: 23093571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Oct; 239(1):136-43. PubMed ID: 2876092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring receptor target coverage: a radioligand competition binding protocol for assessing the association and dissociation rates of unlabeled compounds.
    Sykes DA; Dowling MR; Charlton SJ
    Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.14. PubMed ID: 22294377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for allosteric interactions of antagonist binding to the smoothened receptor.
    Rominger CM; Bee WL; Copeland RA; Davenport EA; Gilmartin A; Gontarek R; Hornberger KR; Kallal LA; Lai Z; Lawrie K; Lu Q; McMillan L; Truong M; Tummino PJ; Turunen B; Will M; Zuercher WJ; Rominger DH
    J Pharmacol Exp Ther; 2009 Jun; 329(3):995-1005. PubMed ID: 19304771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.
    Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD
    Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor.
    Dowling MR; Charlton SJ
    Br J Pharmacol; 2006 Aug; 148(7):927-37. PubMed ID: 16847442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor.
    Bosma R; Stoddart LA; Georgi V; Bouzo-Lorenzo M; Bushby N; Inkoom L; Waring MJ; Briddon SJ; Vischer HF; Sheppard RJ; Fernández-Montalván A; Hill SJ; Leurs R
    Sci Rep; 2019 May; 9(1):7906. PubMed ID: 31133718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Influence of Tracer Kinetics on Competition-Kinetic Association Binding Assays: Identifying the Optimal Conditions for Assessing the Kinetics of Low-Affinity Compounds.
    Sykes DA; Jain P; Charlton SJ
    Mol Pharmacol; 2019 Sep; 96(3):378-392. PubMed ID: 31436538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor.
    Nederpelt I; Bleeker D; Tuijt B; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2016 Oct; 118():88-95. PubMed ID: 27501920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.
    Goldstein A; Barrett RW
    Mol Pharmacol; 1987 Jun; 31(6):603-9. PubMed ID: 3600604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
    Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
    J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCR-radioligand binding assays.
    Flanagan CA
    Methods Cell Biol; 2016; 132():191-215. PubMed ID: 26928545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioligand binding assays and their analysis.
    Maguire JJ; Kuc RE; Davenport AP
    Methods Mol Biol; 2012; 897():31-77. PubMed ID: 22674160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies.
    Raffel DM; Chen W
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):9-16. PubMed ID: 15300361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium.
    Sykes DA; Dowling MR; Leighton-Davies J; Kent TC; Fawcett L; Renard E; Trifilieff A; Charlton SJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):520-8. PubMed ID: 22854200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding kinetics equations: Derivation using the Laplace transform method.
    Hoare SRJ
    J Pharmacol Toxicol Methods; 2018; 89():26-38. PubMed ID: 28818556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.